Used primarily in pharmaceutical research as a potent immunomodulatory agent. It functions as a cereblon E3 ligase modulator, making it valuable in the development of targeted protein degradation therapies, including PROTACs (proteolysis-targeting chimeras). This compound shows strong anti-inflammatory and anti-angiogenic properties, with potential applications in treating autoimmune diseases and various cancers, particularly hematological malignancies. Its ability to enhance degradation of specific disease-causing proteins makes it a key scaffold in designing novel therapeutics for oncology and inflammatory conditions.